Novozymes A/s Stock Forecast

Buy or Hold candidate since Jun 09, 2026 Gain 10.20%

The Novozymes A/S stock price gained 0.85% on the last trading day (Friday, 10th Jul 2026), rising from $64.51 to $65.06. During the last trading day the stock fluctuated 0.81% from a day low at $64.65 to a day high of $65.17. The price has risen in 7 of the last 10 days and is up by 5.16% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 776 more shares were traded than the day before. In total, 3 thousand shares were bought and sold for approximately $187.70 thousand.

The stock lies in the upper part of a wide and weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $65.47 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 4.21% during the next 3 months and, with a 90% probability hold a price between $59.59 and $68.22 at the end of this 3-month period.

NVZMY Signals & Forecast

The Novozymes A/S stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $64.40 and $60.37. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Novozymes A/S has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -0.429%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Novozymes A/S stock

On the downside, the stock finds support just below today's level from accumulated volume at $60.72 and $59.04. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Novozymes A/S finds support just below today's level at $60.72. If this is broken, then the next support from accumulated volume will be at $59.04 and $58.99.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.525 between high and low, or 0.81%. For the last week, the stock has had daily average volatility of 1.22%.

Our recommended stop-loss: $62.64 (-3.73%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (NVZMY) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect Novozymes A/S to open at $64.96, and during the day (based on 14 day Average True Range), to move between $64.34 and $65.78, which gives a possible trading interval of +/-$1.44 (+/-2.23%) up or down from last closing price. If Novozymes A/S takes out the full calculated possible swing range there will be an estimated 2.23% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $65.13 (0.11%) than the support at $60.72 (6.67%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Novozymes A/S stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Novozymes A/S stock to perform well in the short-term.

Current score: 2.035 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $64.96 ( 0.156%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk